CircPrimer: a software for annotating circRNAs and determining the specificity of circRNA primers
Zhong, Shanliang, Wang, Jinyan, Zhang, Qian, Xu, Hanzi, Feng, Jifeng
Published in BMC bioinformatics (03.08.2018)
Published in BMC bioinformatics (03.08.2018)
Get full text
Journal Article
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
Feng, Bing, Wu, Jianzhong, Shen, Bo, Jiang, Feng, Feng, Jifeng
Published in Cancer cell international (29.04.2022)
Published in Cancer cell international (29.04.2022)
Get full text
Journal Article
LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
Zhao, Xia, Li, Xiaoyou, Zhou, Leilei, Ni, Jie, Yan, Wenyue, Ma, Rong, Wu, Jianzhong, Feng, Jifeng, Chen, Ping
Published in Cancer science (01.10.2018)
Published in Cancer science (01.10.2018)
Get full text
Journal Article
LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1
Li, Chenchen, Zhao, Wei, Pan, Xuan, Li, Xiaoyou, Yan, Fei, Liu, Siwen, Feng, Jifeng, Lu, Jianwei
Published in Oncogene (24.09.2020)
Published in Oncogene (24.09.2020)
Get full text
Journal Article
C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis
Zhu, Meng, Ma, Zhimin, Zhang, Xu, Hang, Dong, Yin, Rong, Feng, Jifeng, Xu, Lin, Shen, Hongbing
Published in BMC medicine (19.09.2022)
Published in BMC medicine (19.09.2022)
Get full text
Journal Article
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Wang, Zi-Xian, Cui, Chengxu, Yao, Jun, Zhang, Yanqiao, Li, Mengxia, Feng, Jifeng, Yang, Shujun, Fan, Yun, Shi, Jianhua, Zhang, Xizhi, Shen, Lin, Shu, Yongqian, Wang, Cailian, Dai, Tianyang, Mao, Teng, Chen, Long, Guo, Zengqing, Liu, Bo, Pan, Hongming, Cang, Shundong, Jiang, Yi, Wang, Junye, Ye, Min, Chen, Zhendong, Jiang, Da, Lin, Qin, Ren, Wei, Wang, Junsheng, Wu, Lin, Xu, Yong, Miao, Zhanhui, Sun, Meili, Xie, Conghua, Liu, Ying, Wang, Qifeng, Zhao, Lina, Li, Qi, Huang, Canhong, Jiang, Ke, Yang, Kunyu, Li, Daojun, Liu, Yunpeng, Zhu, Zhitu, Chen, Rixin, Jia, Liqun, Li, Wei, Liao, Wangjun, Liu, Hong-Xu, Ma, Daiyuan, Ma, Jie, Qin, Yanru, Shi, Zhihong, Wei, Qichun, Xiao, Ke, Zhang, Yan, Zhang, Ying, Chen, Xin, Dai, Guanghai, He, Jianxing, Li, Junhe, Li, Guanghui, Liu, Yong, Liu, Zhihua, Yuan, Xianglin, Zhang, Junping, Fu, Zhichao, He, Yifu, Ju, Fang, Liu, Zheng, Tang, Peng, Wang, Tiejun, Wang, Weibo, Zhang, Jing, Luo, Xianming, Tang, Xiongwen, May, Rena, Feng, Hui, Yao, Sheng, Keegan, Patricia, Xu, Rui-Hua, Wang, Feng
Published in Cancer cell (14.03.2022)
Published in Cancer cell (14.03.2022)
Get full text
Journal Article
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
Wu, Yi-Long, Prof, Zhou, Caicun, Prof, Hu, Cheng-Ping, Prof, Feng, Jifeng, Prof, Lu, Shun, Prof, Huang, Yunchao, Prof, Li, Wei, Prof, Hou, Mei, Prof, Shi, Jian Hua, Prof, Lee, Kye Young, Prof, Xu, Chong-Rui, MD, Massey, Dan, MSc, Kim, Miyoung, MD, Shi, Yang, MD, Geater, Sarayut L, MD
Published in The lancet oncology (01.02.2014)
Published in The lancet oncology (01.02.2014)
Get full text
Journal Article
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
Xu, Binghe, Zhang, Qingyuan, Zhang, Pin, Hu, Xichun, Li, Wei, Tong, Zhongsheng, Sun, Tao, Teng, Yuee, Wu, Xinhong, Ouyang, Quchang, Yan, Xi, Cheng, Jing, Liu, Qiang, Feng, Jifeng, Wang, Xiaojia, Yin, Yongmei, Shi, Yanxia, Pan, Yueyin, Wang, Yongsheng, Xie, Weimin, Yan, Min, Liu, Yunjiang, Yan, Ping, Wu, Fei, Zhu, Xiaoyu, Zou, Jianjun
Published in Nature medicine (01.11.2021)
Published in Nature medicine (01.11.2021)
Get full text
Journal Article
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple‐negative breast cancer
Hu, Xichun, Zhang, Jian, Xu, Binghe, Jiang, Zefei, Ragaz, Joseph, Tong, Zhongsheng, Zhang, Qingyuan, Wang, Xiaojia, Feng, Jifeng, Pang, Danmei, Fan, Minhao, Li, Jin, Wang, Biyun, Wang, Zhonghua, Zhang, Qunling, Sun, Si, Liao, Chunmei
Published in International journal of cancer (15.10.2014)
Published in International journal of cancer (15.10.2014)
Get full text
Journal Article
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Zhou, Caicun, Prof, Wu, Yi-Long, Prof, Chen, Gongyan, Prof, Feng, Jifeng, Prof, Liu, Xiao-Qing, Prof, Wang, Changli, Prof, Zhang, Shucai, Prof, Wang, Jie, Prof, Zhou, Songwen, MD, Ren, Shengxiang, MD, Lu, Shun, Prof, Zhang, Li, Prof, Hu, Chengping, Prof, Hu, Chunhong, Prof, Luo, Yi, Prof, Chen, Lei, Prof, Ye, Ming, Prof, Huang, Jianan, Prof, Zhi, Xiuyi, Prof, Zhang, Yiping, Prof, Xiu, Qingyu, Prof, Ma, Jun, Prof, You, Changxuan, Prof
Published in The lancet oncology (01.08.2011)
Published in The lancet oncology (01.08.2011)
Get full text
Journal Article
Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant immunochemotherapy
Zhao, Qiang, Wang, Liang, Yang, Xun, Feng, Jifeng, Chen, Qixun
Published in Frontiers in immunology (05.07.2024)
Published in Frontiers in immunology (05.07.2024)
Get full text
Journal Article
The usefulness of pretreatment controlling nutritional status score for predicting recurrence in patients with esophageal squamous cell carcinoma undergoing neoadjuvant immunochemotherapy: A real-world study
Feng, Jifeng, Wang, Liang, Yang, Xun, Chen, Qixun, Cheng, Xiangdong
Published in Frontiers in immunology (24.11.2022)
Published in Frontiers in immunology (24.11.2022)
Get full text
Journal Article
A novel immune-nutritional score predicts response to neoadjuvant immunochemotherapy after minimally invasive esophagectomy for esophageal squamous cell carcinoma
Feng, Jifeng, Wang, Liang, Yang, Xun, Chen, Qixun, Cheng, Xiangdong
Published in Frontiers in immunology (25.10.2023)
Published in Frontiers in immunology (25.10.2023)
Get full text
Journal Article